Clinic
ST. Mary's Healthcare
ST. Mary's Healthcare was paid $67.34M by Medicaid between Jan 2018 and Dec 2024, across 391 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 12% of everything it billed.
33Billing provider infoST. MARY'S HEALTHCARE
AMSTERDAM, NY 12010
AMSTERDAM, NY 12010
33aNPI1811977796assigned 01/18/2006
33bProvider typePrimary Care Clinic/Center
28Total paid$67.34M
24GClaims1,175,405
24DCodes billed391
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in New York
Rank by total paid#2 of 242
Median peer was paid$172K
This provider vs. median392×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,825 | $1.30M | |
| 2019 | 93,458 | $6.00M | |
| 2020 | 221,470 | $13.61M | |
| 2021 | 253,807 | $13.61M | |
| 2022 | 224,771 | $11.43M | |
| 2023 | 216,787 | $11.96M | |
| 2024incomplete | 154,287 | $9.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 96,049 | 90,302 | $8.41M |
| G9005 | Coordinated care fee, risk adjusted maintenance | 7.8% | 15,017 | 15,012 | $5.27M |
| H0040 | Assertive community treatment program, per diem | 6.7% | 2,510 | 2,509 | $4.50M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.8% | 43,285 | 39,907 | $3.88M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 5.4% | 134,584 | 8,592 | $3.63M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 4.8% | 39,095 | 27,866 | $3.26M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.6% | 25,655 | 21,841 | $2.44M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.6% | 22,124 | 15,694 | $2.41M |
| T2022 | Case management, per month | 2.8% | 4,826 | 4,825 | $1.89M |
| H2016 | Community support for mental illness or disability, billed per dayComprehensive community support services, per diem | 2.8% | 2,720 | 2,717 | $1.89M |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 2.7% | 9,407 | 2,992 | $1.85M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.6% | 14,566 | 14,023 | $1.74M |
379 more codes
| 99284 | Emergency room visit (serious) | 2.3% | 12,891 | $1.57M |
| H2019 | Therapeutic behavioral services, billed per 15 minutes | 2.3% | 2,428 | $1.52M |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 1.8% | 12,752 | $1.18M |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 1.5% | 19,397 | $1.04M |
| 99285 | Emergency room visit (most serious) | 1.4% | 8,274 | $972K |
| S9480 | Intensive outpatient psychiatric services, per diem | 1.4% | 9,613 | $955K |
| 90791 | Psychiatric diagnostic evaluation | 1.3% | 5,522 | $892K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 4,331 | $868K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.1% | 13,829 | $717K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.1% | 19,113 | $714K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 2,720 | $678K |
| 80053 | Comprehensive metabolic panel | <1% | 36,246 | $650K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 6,012 | $596K |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | <1% | 4,635 | $578K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,935 | $525K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 1,735 | $448K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,922 | $410K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 3,848 | $390K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,454 | $389K |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 2,477 | $385K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,739 | $376K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 5,180 | $375K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 3,410 | $372K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,407 | $370K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 622 | $316K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,055 | $309K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 9,479 | $298K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,216 | $277K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,441 | $270K |
| H0001 | Alcohol and/or drug assessment | <1% | 1,802 | $255K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 5,125 | $236K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,026 | $235K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,903 | $208K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,370 | $205K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,140 | $199K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 5,999 | $192K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 6,397 | $192K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15,149 | $175K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 619 | $169K |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | <1% | 165 | $163K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 3,698 | $161K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,637 | $157K |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | <1% | 204 | $149K |
| 59025 | Fetal non-stress test | <1% | 2,092 | $147K |
| 12001 | <1% | 397 | $146K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,480 | $143K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 894 | $142K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 1,415 | $134K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,016 | $122K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,194 | $119K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 5,916 | $116K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,774 | $105K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 861 | $101K |
| 96156 | <1% | 745 | $98K | |
| 80061 | Lipid panel | <1% | 12,809 | $97K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 536 | $88K |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 1,037 | $88K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,030 | $87K |
| 86850 | <1% | 3,203 | $87K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,999 | $85K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 989 | $80K |
| 76830 | Ultrasound, transvaginal | <1% | 1,644 | $78K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,146 | $75K |
| S9083 | Global fee urgent care centers | <1% | 364 | $73K |
| H2018 | Psychosocial rehabilitation services, per diem | <1% | 194 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 41,452 | $73K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,846 | $72K |
| 99000 | <1% | 8,120 | $70K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 55 | $68K |
| 99385 | <1% | 659 | $67K | |
| 88142 | <1% | 2,411 | $66K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 270 | $66K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 90 | $60K |
| 93971 | <1% | 1,028 | $58K | |
| 96160 | <1% | 1,805 | $55K | |
| 86901 | <1% | 3,212 | $54K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 23,721 | $52K |
| 90715 | <1% | 2,353 | $49K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 10,534 | $49K |
| 83655 | <1% | 3,621 | $48K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,956 | $48K |
| 90686 | <1% | 3,729 | $47K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,588 | $47K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,883 | $45K |
| 86900 | <1% | 3,211 | $44K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,366 | $44K |
| 84439 | <1% | 7,247 | $44K | |
| 97161 | <1% | 578 | $44K | |
| 81025 | <1% | 11,947 | $40K | |
| 76770 | <1% | 233 | $39K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,306 | $39K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 837 | $35K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 66 | $33K |
| 88342 | <1% | 849 | $30K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 1,188 | $29K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,172 | $29K |
| 83880 | <1% | 962 | $29K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 74 | $27K |
| G0378 | Hospital observation service, per hour | <1% | 553 | $27K |
| 82607 | <1% | 2,857 | $27K | |
| 87081 | <1% | 12,019 | $26K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 4,810 | $25K |
| 82728 | <1% | 2,597 | $25K | |
| 90670 | <1% | 1,962 | $23K | |
| 76536 | <1% | 749 | $22K | |
| 70486 | <1% | 225 | $22K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,610 | $22K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 654 | $21K |
| 71250 | <1% | 218 | $21K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,121 | $21K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,764 | $19K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,947 | $19K |
| 82746 | <1% | 1,907 | $18K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 3,014 | $17K |
| J2680 | Injection, fluphenazine decanoate, up to 25 mg | <1% | 1,792 | $17K |
| 90674 | <1% | 860 | $17K | |
| 84153 | <1% | 1,191 | $16K | |
| 64615 | <1% | 38 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 906 | $14K |
| 87800 | <1% | 374 | $14K | |
| 85610 | <1% | 5,446 | $13K | |
| 99386 | <1% | 127 | $13K | |
| 99205 | Prolong outpt/office vis | <1% | 125 | $13K |
| 83540 | <1% | 3,151 | $12K | |
| 94010 | <1% | 150 | $12K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 588 | $12K |
| 84702 | <1% | 2,062 | $12K | |
| 81001 | <1% | 10,394 | $12K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 491 | $11K |
| 90651 | <1% | 412 | $11K | |
| G9001 | Coordinated care fee, initial rate | <1% | 140 | $11K |
| 51798 | <1% | 38 | $10K | |
| H0046 | Mental health services, not otherwise specified | <1% | 140 | $10K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 41 | $10K |
| 90680 | <1% | 1,622 | $10K | |
| 99442 | <1% | 191 | $10K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 36 | $10K |
| 86762 | <1% | 1,361 | $9K | |
| 86803 | <1% | 1,602 | $9K | |
| 87481 | <1% | 272 | $9K | |
| 72110 | <1% | 699 | $9K | |
| 85027 | <1% | 3,406 | $9K | |
| 82043 | <1% | 2,344 | $9K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 60 | $8K |
| 99173 | <1% | 182 | $8K | |
| 88304 | <1% | 317 | $8K | |
| 99381 | <1% | 74 | $7K | |
| 81003 | <1% | 9,923 | $7K | |
| 80306 | <1% | 4,421 | $7K | |
| 73562 | <1% | 1,690 | $7K | |
| 99406 | <1% | 1,489 | $7K | |
| 76642 | <1% | 267 | $7K | |
| 80076 | <1% | 890 | $7K | |
| 86618 | <1% | 505 | $7K | |
| 73630 | <1% | 2,122 | $7K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,498 | $7K |
| 85730 | <1% | 4,256 | $7K | |
| 83735 | <1% | 5,130 | $6K | |
| 90698 | <1% | 1,955 | $6K | |
| 87186 | <1% | 2,733 | $6K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 132 | $6K |
| 86038 | <1% | 1,356 | $6K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 142 | $6K |
| 73030 | <1% | 1,362 | $6K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 44 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,071 | $5K |
| 82784 | <1% | 519 | $5K | |
| 99383 | <1% | 50 | $5K | |
| 74019 | <1% | 938 | $5K | |
| 90744 | <1% | 1,219 | $5K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 555 | $5K |
| 71271 | <1% | 202 | $5K | |
| 73610 | <1% | 1,928 | $5K | |
| 86140 | <1% | 1,558 | $5K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 359 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,350 | $5K |
| 93970 | <1% | 12 | $5K | |
| 90633 | <1% | 1,392 | $5K | |
| 86617 | <1% | 241 | $5K | |
| 87077 | <1% | 1,549 | $5K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 141 | $5K |
| 87340 | <1% | 1,205 | $5K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 44 | $5K |
| 12002 | <1% | 12 | $5K | |
| 85652 | <1% | 2,919 | $5K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 13 | $4K |
| 76641 | <1% | 144 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $4K |
| 72100 | <1% | 623 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 141 | $4K |
| J3490 | Unclassified drugs | <1% | 164 | $4K |
| 84403 | <1% | 189 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 141 | $4K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 12 | $4K |
| 11721 | <1% | 74 | $4K | |
| 82950 | <1% | 743 | $4K | |
| 86787 | <1% | 1,073 | $4K | |
| 99051 | <1% | 329 | $4K | |
| 73130 | <1% | 1,341 | $4K | |
| 82248 | <1% | 1,709 | $4K | |
| 80069 | <1% | 439 | $4K | |
| 83690 | <1% | 5,475 | $4K | |
| 96161 | <1% | 97 | $4K | |
| 90734 | <1% | 839 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,066 | $3K |
| 87088 | <1% | 1,440 | $3K | |
| 90620 | <1% | 341 | $3K | |
| 76775 | <1% | 84 | $3K | |
| 90716 | <1% | 225 | $3K | |
| 82570 | <1% | 780 | $3K | |
| 86769 | <1% | 94 | $3K | |
| 99443 | <1% | 44 | $3K | |
| 86592 | <1% | 1,611 | $3K | |
| 0012A | <1% | 130 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,109 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 55 | $3K |
| 84484 | <1% | 6,265 | $3K | |
| 96150 | <1% | 217 | $3K | |
| 73110 | <1% | 1,088 | $3K | |
| 84550 | <1% | 715 | $3K | |
| 99460 | <1% | 39 | $3K | |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 14 | $3K |
| 84436 | <1% | 696 | $3K | |
| 82150 | <1% | 1,818 | $2K | |
| 86003 | <1% | 42 | $2K | |
| 86430 | <1% | 569 | $2K | |
| 74018 | <1% | 742 | $2K | |
| G0008 | Administration of influenza virus vaccine | <1% | 199 | $2K |
| 85379 | <1% | 1,561 | $2K | |
| 87205 | <1% | 1,182 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,128 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $2K |
| 0011A | <1% | 123 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,451 | $2K |
| 83970 | <1% | 44 | $2K | |
| 90707 | <1% | 246 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 41 | $2K |
| 90656 | <1% | 177 | $2K | |
| 77065 | Tomosynthesis, mammo | <1% | 26 | $2K |
| 77066 | Tomosynthesis, mammo | <1% | 24 | $2K |
| 86480 | <1% | 33 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 41 | $2K |
| 86141 | <1% | 248 | $2K | |
| 99384 | <1% | 13 | $1K | |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 20 | $1K |
| 77080 | <1% | 24 | $1K | |
| 73502 | <1% | 361 | $1K | |
| 69210 | <1% | 12 | $1K | |
| 90710 | <1% | 520 | $1K | |
| 84481 | <1% | 115 | $1K | |
| 84480 | <1% | 305 | $1K | |
| 81513 | <1% | 300 | $1K | |
| 73140 | <1% | 629 | $927.21 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 411 | $921.17 |
| 87040 | <1% | 1,604 | $901.46 | |
| 83605 | <1% | 1,614 | $890.43 | |
| 90696 | <1% | 315 | $868.43 | |
| 82550 | <1% | 793 | $853.26 | |
| 94760 | <1% | 8,030 | $812.12 | |
| 84681 | <1% | 40 | $805.35 | |
| 99459 | <1% | 37 | $794.76 | |
| 90661 | <1% | 29 | $783.72 | |
| 84703 | <1% | 1,233 | $758.22 | |
| 96376 | <1% | 547 | $724.12 | |
| 82308 | <1% | 27 | $723.33 | |
| 81002 | <1% | 3,423 | $687.13 | |
| 90474 | <1% | 286 | $680.00 | |
| 86308 | <1% | 215 | $636.48 | |
| 85007 | <1% | 595 | $607.87 | |
| 82627 | <1% | 27 | $600.21 | |
| 70360 | <1% | 93 | $592.86 | |
| 87147 | <1% | 2,222 | $575.55 | |
| 72070 | <1% | 66 | $575.26 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 46 | $494.32 |
| 90671 | <1% | 441 | $458.76 | |
| 99221 | <1% | 13 | $453.70 | |
| 85014 | <1% | 485 | $437.69 | |
| 90733 | <1% | 49 | $410.55 | |
| 86580 | <1% | 86 | $398.15 | |
| 86376 | <1% | 39 | $388.85 | |
| 84154 | <1% | 26 | $386.19 | |
| 84402 | <1% | 15 | $382.05 | |
| 87660 | <1% | 129 | $368.15 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 12 | $360.95 |
| 73080 | <1% | 116 | $359.26 | |
| 85018 | <1% | 426 | $356.98 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,146 | $354.35 |
| 86765 | <1% | 28 | $347.76 | |
| 95806 | <1% | 13 | $319.00 | |
| 86709 | <1% | 37 | $310.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 3,790 | $309.58 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,420 | $275.24 |
| 87807 | <1% | 180 | $266.10 | |
| 86735 | <1% | 37 | $264.99 | |
| 87468 | <1% | 12 | $258.69 | |
| 99441 | <1% | 13 | $254.44 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 16 | $238.35 |
| 82553 | <1% | 558 | $223.18 | |
| 86665 | <1% | 22 | $219.80 | |
| 84100 | <1% | 105 | $211.59 | |
| 72050 | <1% | 24 | $208.00 | |
| 87045 | <1% | 36 | $203.75 | |
| 87510 | <1% | 108 | $197.21 | |
| 87480 | <1% | 108 | $197.21 | |
| 86160 | <1% | 12 | $194.04 | |
| 71101 | <1% | 147 | $189.65 | |
| 87484 | <1% | 13 | $183.47 | |
| 90662 | <1% | 133 | $173.35 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,760 | $157.93 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 1,843 | $157.40 |
| J2704 | Injection, propofol, 10 mg | <1% | 4,042 | $155.99 |
| 83001 | <1% | 12 | $152.54 | |
| 83529 | <1% | 14 | $146.44 | |
| 87478 | <1% | 12 | $140.19 | |
| 87469 | <1% | 12 | $140.19 | |
| C9399 | Unclassified drugs or biologicals | <1% | 14 | $134.70 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,359 | $132.34 |
| 90677 | <1% | 20 | $122.60 | |
| 87328 | <1% | 12 | $118.40 | |
| 87329 | <1% | 12 | $118.40 | |
| 86800 | <1% | 13 | $117.94 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 593 | $114.46 |
| 86664 | <1% | 12 | $107.33 | |
| 73620 | <1% | 40 | $106.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,166 | $102.00 |
| 86705 | <1% | 13 | $101.00 | |
| 87046 | <1% | 24 | $100.30 | |
| 86663 | <1% | 12 | $97.69 | |
| 82105 | <1% | 16 | $97.50 | |
| 84146 | <1% | 12 | $96.90 | |
| 72081 | <1% | 12 | $93.74 | |
| 82140 | <1% | 25 | $87.42 | |
| 73090 | <1% | 71 | $82.80 | |
| 83615 | <1% | 31 | $80.89 | |
| 83874 | <1% | 541 | $78.18 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 520 | $73.12 |
| 87324 | <1% | 12 | $65.80 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,407 | $62.14 |
| 94727 | <1% | 12 | $60.58 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,341 | $59.25 |
| 82565 | <1% | 13 | $58.91 | |
| 72040 | <1% | 13 | $52.08 | |
| 84156 | <1% | 13 | $49.83 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,171 | $45.65 |
| 94729 | <1% | 13 | $43.68 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 68 | $40.29 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 444 | $40.26 |
| 96127 | <1% | 3,373 | $37.19 | |
| 87449 | <1% | 12 | $36.40 | |
| 73590 | <1% | 28 | $36.00 | |
| 82948 | <1% | 359 | $33.50 | |
| 73560 | <1% | 14 | $24.72 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,744 | $24.22 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,012 | $19.09 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 335 | $12.39 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,986 | $11.81 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 140 | $7.15 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 61 | $6.70 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 94 | $4.28 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 121 | $3.56 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 20 | $3.46 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 114 | $1.66 |
| J2251 | Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg | <1% | 178 | $1.00 |
| M1069 | Patient screened for future fall risk | 0% | 640 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 477 | $0.00 |
| 82962 | 0% | 14 | $0.00 | |
| 88300 | 0% | 14 | $0.00 | |
| 90647 | 0% | 27 | $0.00 | |
| 90723 | 0% | 34 | $0.00 | |
| 82803 | 0% | 18 | $0.00 | |
| 80359 | 0% | 15 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 841 | $0.00 |
| 82075 | 0% | 91 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 70 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 37 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 27 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 60 | $0.00 |
| 90473 | 0% | 12 | $0.00 | |
| 99360 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMETHVEN, JEFFREY (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| ST. Mary's Healthcare | Amsterdam, NY | $298K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.